MedPath

Evaluation of plasma glucose change by Libre Pro shortly after hospital discharge in type 2 diabetes with multiple daily insulin injection method

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-UMIN000035148
Lead Sponsor
Toho University School of Medicine, Division of Diabetes, Metabolism and Endocrinology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Type 1 diabetes mellitus patients (2) Patients with severe liver disease (3) Patients with severe renal disease (4) Patients who had myocardial infarction within 3 months, or obvious heart failure case (5) Patients with severe pancreas disease (6) Patients having a cancer (7) Patients with hemoglobin (Hb) less than 11 g/dL (8) Patients that the number of the platelets is less than 100,000 /mm3 (9) Patients with high diabetic neuropathy (10) Patients having a proliferative retinopathy (11) Patients with a serious infectious disease or a serious injury (12) Patients with bowel disease or ileus factors (13) Chronic enteropathy patients with the digestion and absorption abnormality (14) Excessive common custom drinker (15) A pregnant woman or the woman who may be pregnant (16) Patients who was infected with hepatitis B virus or hepatitis C virus (17) In addition, the patient who judged inappropriate by an attendant physician

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hypoglycemia (value, frequency, appearance time and duration)
Secondary Outcome Measures
NameTimeMethod
Changes in the amount of insulin, Difference due to insulin preparation
© Copyright 2025. All Rights Reserved by MedPath